Krishnan Krish S — SEC Form 4 filings
SEC reporting owner CIK 1298709. 15 Form 4 filings on record with FilingPulse; latest filed 2026-09-04.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-02-28 to 2026-09-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 137 legs across 11 filings — 425,000 shares, $86,144,119 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 41.
- Largest priced transaction: sale of 11,461 shares @ $307.68 ($3,526,293) in Krystal Biotech, Inc., filed 2026-06-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | President and CEO, Director, 10% owner | 15 | — | 137 legs · 425,000 sh · $86,144,119 | 41 |
Form 4 filings — Krishnan Krish S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-04 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 520 @ $354.54 · Sale (S): 2,029 @ $355.57 · Sale (S): 3,297 @ $356.37 · Sale (S): 3,981 @ $357.57 · Sale (S): 3,143 @ $358.42 · Sale (S): 3,357 @ $359.39 · +7 more | EDGAR |
| 2026-06-05 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 320 @ $300.75 · Sale (S): 640 @ $302.24 · Sale (S): 176 @ $303.17 · Sale (S): 544 @ $304.81 · Sale (S): 589 @ $306.33 · Sale (S): 11,461 @ $307.68 · +5 more | EDGAR |
| 2026-03-06 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 483 @ $257.31 · Sale (S): 470 @ $258.38 · Sale (S): 1,377 @ $259.87 · Sale (S): 3,128 @ $260.49 · Sale (S): 2,962 @ $261.41 · Sale (S): 2,380 @ $262.44 · +4 more | EDGAR |
| 2026-03-03 | 4 | Krystal Biotech, Inc. (KRYS) | Option exercise (M): 8,750 @ $0 · Tax withholding (F): 3,981 @ $275.64 · Option exercise (M): 26,250 @ $0 · Tax withholding (F): 11,942 @ $275.64 · Option exercise (M): 5,725 @ $0 · Tax withholding (F): 2,605 @ $275.64 · +9 more | EDGAR |
| 2025-12-05 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 956 @ $214.28 · Sale (S): 344 @ $215.48 · Sale (S): 1,600 @ $217.04 · Sale (S): 2,577 @ $218.72 · Sale (S): 5,693 @ $219.55 · Sale (S): 2,625 @ $220.34 · +11 more | EDGAR |
| 2025-07-16 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 13,400 @ $150.30 · Sale (S): 2,184 @ $150.68 · Sale (S): 900 @ $151.79 · Sale (S): 1,389 @ $150 · Sale (S): 13,335 @ $150.29 · Sale (S): 100 @ $151 · +3 more | EDGAR |
| 2025-07-11 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 200 @ $150.07 · Sale (S): 6,627 @ $150.22 · Sale (S): 300 @ $151.39 · Sale (S): 200 @ $150.14 · Sale (S): 6,500 @ $150.23 · Sale (S): 300 @ $151.39 | EDGAR |
| 2025-03-13 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 1,100 @ $175.83 · Sale (S): 4,944 @ $176.80 · Sale (S): 10,931 @ $177.62 · Sale (S): 6,769 @ $178.77 · Sale (S): 1,256 @ $179.57 · Sale (S): 1,639 @ $175.97 · +4 more | EDGAR |
| 2025-02-28 | 4 | Krystal Biotech, Inc. (KRYS) | Tax withholding (F): 4,721 @ $176.39 · Option exercise (M): 12,500 @ $0 · Tax withholding (F): 5,786 @ $179.25 · Option exercise (M): 8,750 @ $0 · Tax withholding (F): 4,050 @ $179.25 · Option exercise (M): 26,250 @ $0 · +11 more | EDGAR |
| 2024-12-13 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 6,302 @ $163.07 · Sale (S): 8,381 @ $163.91 · Sale (S): 4,909 @ $164.93 · Sale (S): 1,977 @ $165.82 · Sale (S): 923 @ $166.93 · Sale (S): 911 @ $169.65 · +11 more | EDGAR |
| 2024-09-13 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 3,957 @ $195.16 · Sale (S): 6,458 @ $195.72 · Sale (S): 1,696 @ $197.04 · Sale (S): 2,086 @ $198.08 · Sale (S): 4,008 @ $198.93 · Sale (S): 3,600 @ $200.15 · +9 more | EDGAR |
| 2024-06-11 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 1,100 @ $171.49 · Sale (S): 1,882 @ $172.21 · Sale (S): 1,318 @ $173.49 · Sale (S): 4,000 @ $174.83 · Sale (S): 4,550 @ $175.76 · Sale (S): 5,705 @ $176.68 · +10 more | EDGAR |
| 2024-03-11 | 4 | Krystal Biotech, Inc. (KRYS) | Sale (S): 2,146 @ $167.99 · Sale (S): 2,254 @ $168.88 · Sale (S): 5,109 @ $170.32 · Sale (S): 8,002 @ $170.93 · Sale (S): 2,816 @ $172.06 · Sale (S): 3,359 @ $173.09 · +8 more | EDGAR |
| 2024-03-01 | 4 | Krystal Biotech, Inc. (KRYS) | Option exercise (M): 12,500 @ $0 · Tax withholding (F): 5,785 @ $163.08 · Option exercise (M): 7,500 @ $0 · Tax withholding (F): 3,471 @ $163.08 · Option exercise (M): 12,500 (derivative) @ $0 · Grant/award (A): 35,000 (derivative) @ $0 · +1 more | EDGAR |
| 2024-02-28 | 4 | Krystal Biotech, Inc. (KRYS) | Tax withholding (F): 3,791 @ $157 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1298709 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →